MétaCan
Menu
← Back to cohort
Record W2792351819 · doi:10.1093/ecco-jcc/jjx180.058

DOP021 Immunosuppressive and anti-TNF treatment is associated with a lower risk of migration from B1-to-B3-stage in Crohn’s disease: 10-year follow-up data from the Swiss IBD cohort study

2018· article· en· W2792351819 on OpenAlexaboutno aff
Patrick Cernoch, Nicolas Fournier, Michael Scharl, Jonas Zeitz, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain Schoepfer, S Vavricka, Gerhard Rogler, Luc Biedermann

Bibliographic record

VenueJournal of Crohn s and Colitis · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineStage (stratigraphy)Crohn's diseaseCohortDiseaseInflammatory bowel diseaseInternal medicineFistulaMultivariate analysisGastroenterologySurgery

Abstract

fetched live from OpenAlex

Our knowledge on the evolution of disease behaviour remains scarce after the introduction of anti-TNF. We investigated the long-term evolution of B-Stage in CD patients in the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Prospectively collected SIBDCS data on all CD patients was analysed regarding B-Stage (B1 = inflammatory, B2 = stricturing, B3 = penetrating) evolution over time according to treatment. We deliberately used an extended definition of penetrating disease, including perianal fistula into B3, due to a substantial morbidity, not exceedingly different to non-perianal fistula (constituting the classical definition of a B3 stage according to Montreal). Of 1471 CD patients, 1042 had a non-B3 phenotype at enrolment, amongst of which 645 never had previously been treated with anti-TNF and thus were eligible for further analysis. Overall, 95.2 and 78.4% of initial B1 patients remained in this stage after 1 and 5 years, respectively. Yet, after 15 years only 48.1% revealed a sustained B1 phenotype with 32.1 and 19.8% having migrated to a B2 and B3 stage, respectively. In multivariate testing, patients aged >40 years at diagnosis were significantly less likely to progress from B1 to B3 (HR 0.378). With regards to treatment with anti-TNF we predefined a separate analysis for patients with initiation of treatment >1 years vs. within 1 year or less prior to the event of stage migration, as the latter may indeed reflect an attempt of treatment escalation in the event of imminent or already having occurred therefore undiagnosed B-stage progression. We found both immunosuppressants (IS) and persistent treatment with anti-TNF to be significantly associated with a decreased likelihood of B1-to-B3 progression as compared with CD patients without treatment with IS and/or anti-TNF. Signifikant Risk factors for B-Stage migration: multivariate analysis. Significant risk factors for a change in disease behaviour over time according to multivariate testing. Significant hazard ratios (HR) are printed in bold type. In our prospective cohort study, we identified a beneficial effect of both, IS and sustained anti-TNF on the risk of B1-to-B3 migration in CD patients on the long-term as opposed to their treatment naïve counterparts or patients having stopped anti-TNF treatment. Evidently, a randomised long-term study would be preferential to investigate the potential of medical interventions on modifying the risk of B-stage migration, due to a high likelihood of selection bias towards more vs. less favourable prognosis in patients in the IS-and-anti-TNF-naïve vs. anti-TNF exposed groups, respectively. Therefore, the results from our study suggest a potentially even more robust beneficial effect of IS and anti-TNF on long-term B-stage migration.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.252
Teacher spread0.242 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→